PL2306970T3 - Zastosowanie kosmetyczne Lactobacillus paracasei w leczeniu skóry tłustej - Google Patents

Zastosowanie kosmetyczne Lactobacillus paracasei w leczeniu skóry tłustej

Info

Publication number
PL2306970T3
PL2306970T3 PL09802596T PL09802596T PL2306970T3 PL 2306970 T3 PL2306970 T3 PL 2306970T3 PL 09802596 T PL09802596 T PL 09802596T PL 09802596 T PL09802596 T PL 09802596T PL 2306970 T3 PL2306970 T3 PL 2306970T3
Authority
PL
Poland
Prior art keywords
treatment
lactobacillus paracasei
cosmetic use
oily skin
oily
Prior art date
Application number
PL09802596T
Other languages
English (en)
Polish (pl)
Inventor
Isabelle Castiel
Audrey Gueniche
Original Assignee
Oreal
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal, Nestec Sa filed Critical Oreal
Publication of PL2306970T3 publication Critical patent/PL2306970T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL09802596T 2008-07-29 2009-07-23 Zastosowanie kosmetyczne Lactobacillus paracasei w leczeniu skóry tłustej PL2306970T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8458008P 2008-07-29 2008-07-29
FR0857866A FR2938437B1 (fr) 2008-11-19 2008-11-19 Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
EP09802596.8A EP2306970B1 (en) 2008-07-29 2009-07-23 Cosmetic use of Lactobacillus paracasei for the treatment of oily skin
PCT/IB2009/053204 WO2010013179A1 (en) 2008-07-29 2009-07-23 Cosmetic use of microorganisms for the treatment of oily skin

Publications (1)

Publication Number Publication Date
PL2306970T3 true PL2306970T3 (pl) 2015-03-31

Family

ID=40834534

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09802596T PL2306970T3 (pl) 2008-07-29 2009-07-23 Zastosowanie kosmetyczne Lactobacillus paracasei w leczeniu skóry tłustej

Country Status (10)

Country Link
US (1) US8951775B2 (https=)
EP (1) EP2306970B1 (https=)
JP (1) JP2011529484A (https=)
CN (1) CN102105132B (https=)
BR (1) BRPI0916693A2 (https=)
ES (1) ES2524367T3 (https=)
FR (1) FR2938437B1 (https=)
PL (1) PL2306970T3 (https=)
PT (1) PT2306970E (https=)
WO (1) WO2010013179A1 (https=)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9642877B1 (en) * 2016-01-06 2017-05-09 Kenneth O. Russell Method of administration of chromium and magnesium sulfate for treatment of acne
FR2953407B1 (fr) * 2009-12-08 2013-06-14 Oreal Microorganismes probiotiques a titre d'actif contre les alterations du microrelief
FR2953408B1 (fr) * 2009-12-08 2013-02-08 Oreal Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau
US8465731B2 (en) * 2010-03-12 2013-06-18 Elc Management, Llc Probiotic color cosmetic compositions and methods
CN102477446B (zh) * 2010-11-25 2014-03-19 花王株式会社 神经酰胺和/或葡萄糖神经酰胺产生促进剂的制造方法
CN102994558B (zh) * 2011-09-15 2014-07-16 花王株式会社 神经酰胺产生促进剂的制造方法
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US10583033B2 (en) 2011-02-04 2020-03-10 Katherine Rose Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US10940169B2 (en) 2015-11-30 2021-03-09 Joseph E. Kovarik Method for reducing the likelihood of developing cancer in an individual human being
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10085938B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US10010568B2 (en) 2011-02-04 2018-07-03 Katherine Rose Kovarik Method and system for reducing the likelihood of a spirochetes infection in a human being
US10111913B2 (en) 2011-02-04 2018-10-30 Joseph E. Kovarik Method of reducing the likelihood of skin cancer in an individual human being
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US11191665B2 (en) 2011-02-04 2021-12-07 Joseph E. Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US10086018B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10835560B2 (en) 2013-12-20 2020-11-17 Joseph E. Kovarik Reducing the likelihood of skin cancer in an individual human being
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US10548761B2 (en) 2011-02-04 2020-02-04 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
JP5774884B2 (ja) * 2011-03-29 2015-09-09 日本メナード化粧品株式会社 アクネ菌のバイオフィルム形成阻害剤
PL2704704T3 (pl) * 2011-05-03 2019-04-30 Dupont Nutrition Biosci Aps Bakterie probiotyczne do miejscowego leczenia zaburzeń skóry
CN103957997B (zh) * 2011-10-25 2018-09-21 奥麒个人护理产品公司 含有顺序发酵或同时发酵的提取物的组合物
GB201206599D0 (en) * 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
CN102755281A (zh) * 2012-07-13 2012-10-31 无锡紫昂生物科技有限公司 一种含有微生物调节剂的化妆品
FR2996452B1 (fr) * 2012-10-05 2017-01-13 Oreal Propionibacterium freudenreichii en tant qu'actif contre les peaux grasses a tendance acneique
FR2996451B1 (fr) * 2012-10-05 2015-09-04 Oreal Propionibacterium freudenreichii en tant qu'actif cosmetique contre les peaux grasses
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11672835B2 (en) 2013-12-20 2023-06-13 Seed Health, Inc. Method for treating individuals having cancer and who are receiving cancer immunotherapy
US11642382B2 (en) 2013-12-20 2023-05-09 Seed Health, Inc. Method for treating an individual suffering from bladder cancer
US12318377B2 (en) 2013-12-20 2025-06-03 Seed Health, Inc. Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11213552B2 (en) 2015-11-30 2022-01-04 Joseph E. Kovarik Method for treating an individual suffering from a chronic infectious disease and cancer
US11026982B2 (en) 2015-11-30 2021-06-08 Joseph E. Kovarik Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11529379B2 (en) 2013-12-20 2022-12-20 Seed Health, Inc. Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
ES3025685T3 (en) 2014-06-17 2025-06-09 Crown Laboratories Inc Genetically modified bacteria and methods for genetic modification of bacteria
IL286488B2 (en) * 2015-07-02 2025-11-01 Aobiome Llc A preparation comprising ammonia oxidising bacteria for use in a method of treating eczema or rosacea
ITUB20153106A1 (it) * 2015-08-13 2017-02-13 Probiotical Spa Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne
US20180311144A1 (en) * 2015-10-15 2018-11-01 Natura Cosméticos S.A. Cosmetic composition having probiotic bacteria
US10675347B2 (en) 2015-11-30 2020-06-09 Joseph E. Kovarik Method and system for protecting honey bees from fipronil pesticides
US10568916B2 (en) 2015-11-30 2020-02-25 Joseph E. Kovarik Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
US11529412B2 (en) 2015-11-30 2022-12-20 Seed Health, Inc. Method and system for protecting honey bees from pesticides
US10933128B2 (en) 2015-11-30 2021-03-02 Joseph E. Kovarik Method and system for protecting honey bees from pesticides
US12239706B2 (en) 2015-11-30 2025-03-04 Seed Health, Inc. Method and system for protecting monarch butterflies from pesticides
US10086024B2 (en) 2015-11-30 2018-10-02 Joseph E. Kovarik Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
JP6185041B2 (ja) * 2015-12-04 2017-08-23 一丸ファルコス株式会社 表皮ブドウ球菌由来のグリセロール産生促進剤、皮膚表皮角化細胞由来の抗菌ペプチド産生促進剤、およびそれらの皮膚保護用外用剤への利用
LT6463B (lt) 2015-12-10 2017-10-10 Uab "Probiosanus" Probiotinių bakterijų (pb) gyvybingumo ir stabilumo padidinimas detergentų turinčiuose asmens higienos ir buities priežiūros produktuose
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
EP3435765A1 (en) 2016-03-31 2019-02-06 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
AU2017240069B2 (en) 2016-03-31 2024-03-07 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
EP3448398A4 (en) 2016-04-21 2019-12-18 Naked Biome, Inc. COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES
WO2018051895A1 (ja) 2016-09-15 2018-03-22 キリン株式会社 乳酸菌を有効成分として含む、皮膚における特定細菌の異常増殖に起因する皮膚の状態の悪化を防止又は改善するための組成物
CN106265479A (zh) * 2016-10-27 2017-01-04 广州仙施生物科技有限公司 一种皮肤修复组合物及其制备方法
US10258567B1 (en) 2016-11-17 2019-04-16 Grace Procurements Llc Vaginal probiotic products and related processes
EP3544575A1 (en) 2016-11-23 2019-10-02 GOJO Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2018109018A1 (fr) * 2016-12-16 2018-06-21 Nestle Skin Health Sa Capsule comprenant un microorganisme probiotique pour utilisation dans un dispositif de production et de distribution de compositions
JP6994214B2 (ja) * 2017-05-01 2022-02-21 日本コルマー株式会社 皮膚改善用食品組成物
CN110622624A (zh) * 2017-05-08 2019-12-27 莱雅公司 用于调节角蛋白基质微生物群的用化学或有机化合物进行的大气压冷等离子体处理
JP7150753B2 (ja) * 2017-06-06 2022-10-11 サミ－サビンサ グループ リミテッド バチルス・コアグランス由来の細胞外代謝産物調製物を含むヘアケア組成物
KR102394642B1 (ko) 2017-09-15 2022-05-09 (주)아모레퍼시픽 바실러스 화진포엔시스의 배양물 또는 이의 추출물을 포함하는 피부 미백용 조성물
CN111511379B (zh) * 2017-12-06 2024-06-18 Lac2生物群系有限公司 基于益生菌的组合物及其应用
US12150967B2 (en) 2018-08-18 2024-11-26 Seed Health, Inc. Methods and compositions for honey bee health
CN111374896A (zh) * 2018-12-28 2020-07-07 西安臻瑞生物科技有限公司 一种治疗痤疮的益生元和益生菌护肤品及其制备方法
MX2021008460A (es) * 2019-01-15 2021-09-08 Novozymes As Composición probiótica a base de esporas para modulación de propiedades dérmicas y subdérmicas.
CN113316441A (zh) 2019-01-31 2021-08-27 金伯利-克拉克环球有限公司 通过微生物的选择性代谢功能来动态控制环境的方法和产品
CN110093286B (zh) * 2019-03-19 2021-12-17 江南大学 假小链双歧杆菌ccfm1046、其组合物、发酵食品、用途、菌剂及其菌剂制备方法
CL2019000845A1 (es) * 2019-03-29 2019-08-30 Monje Marcela Maritza Espinoza Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar
KR102058622B1 (ko) 2019-08-27 2019-12-23 주식회사 아미코스메틱 여드름 유발 피부상재균에 대한 항균 활성을 갖는 락토바실러스 쿠르바투스
CN110507598A (zh) * 2019-09-10 2019-11-29 河北一然生物科技有限公司 乳酸菌在抑制痤疮丙酸杆菌中的应用及用其制成的护肤品
CN111202709A (zh) * 2019-12-11 2020-05-29 河北一然生物科技有限公司 一种能够抑制痤疮丙酸杆菌的乳酸菌面膜及制备方法
KR102277957B1 (ko) * 2020-03-11 2021-07-16 주식회사 엘지생활건강 피부 유익균 증진용 화장료 조성물
CA3183350A1 (en) 2020-06-23 2021-12-30 Thomas M. Hitchcock Probiotic skin formulations
KR102244812B1 (ko) * 2020-09-23 2021-04-28 (주)에스디생명공학 락토바실러스 플란타룸 아종 플란타룸 sdcm 1002 및 사카로마에세스 세르비지에 sdcm 3017의 혼합 균주, 그 배양액, 또는 이의 추출물을 유효성분으로 포함하는 조성물
US20220110918A1 (en) * 2020-10-09 2022-04-14 Script Essentials, Llc Compositions and methods for treatment of skin-related diseases and promoting dermatological health
CN116568292A (zh) * 2020-11-05 2023-08-08 莱托生物股份有限公司 用于治疗皮肤病症的新组合物
KR102643628B1 (ko) * 2020-12-10 2024-03-04 민흥기 유산균을 함유하는 비립종 개선용 조성물
FR3124077B1 (fr) * 2021-06-22 2025-05-02 Univ Nanyang Tech Utilisation d ’ un acide gras à cha î ne courte comme agent antipelliculaire
BR112023012330A2 (pt) * 2020-12-21 2023-11-14 Oreal Usos cosméticos e processos cosméticos
KR20230143154A (ko) * 2021-02-01 2023-10-11 아지트라 인코포레이티드 유전자 조작된 박테리아에서 단백질 발현을 증가시키기 위한 방법 및 조성물
EP4355296A4 (en) * 2021-06-15 2025-05-14 Jeen International Corp. TOPICAL PROBIOTIC DELIVERY SYSTEM
CN113632990A (zh) * 2021-09-03 2021-11-12 上海楷达生物科技有限公司 一种能促进玻尿酸和胶原合成的美容益生菌组合物
CN114717134B (zh) * 2021-11-15 2023-11-21 青岛蔚蓝生物股份有限公司 一株乳双歧杆菌及其在防治痤疮中的应用
CN117363528A (zh) * 2023-06-27 2024-01-09 深圳市波尔顿科技有限公司 具有肠炎治疗作用的长双歧杆菌及其应用
CN118325798B (zh) * 2024-06-17 2024-08-30 青岛诺和诺康生物科技有限公司 一株减少头皮屑及毛囊炎的鼠李糖乳酪杆菌nhnk-604及其制品和应用
KR102829083B1 (ko) * 2024-09-11 2025-07-04 일동바이오사이언스(주) 여드름 개선을 위한 비피도박테리움 비피덤 idcc 4201 균주를 포함하는 조성물 및 건강기능식품

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1136429A (zh) * 1995-01-24 1996-11-27 康白 微生态制剂美容霜及其制备方法
DE69832267T2 (de) * 1997-04-18 2006-08-10 Ganeden Biotech, Inc., La Jolla Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
ATE490776T1 (de) 2000-10-06 2010-12-15 Nestec Sa Verwendung von probiotischen milchsäure- produzierende bakterien zur zum schutz der haut gegen uv-induzierter allergischen reaktionen und entzündungskrankheiten oder immunsuppression
AUPS057102A0 (en) 2002-02-15 2002-03-07 Vri Biomedical Ltd Compositions and methods for treatment of skin disorders
MXPA04008182A (es) 2002-02-21 2005-06-08 Oreal Composicion fotoprotectora para la piel, oralmente adminstrable.
JP4037186B2 (ja) * 2002-06-21 2008-01-23 ニチニチ製薬株式会社 尋常性ざ瘡治療剤
CN1767839B (zh) * 2003-03-13 2012-08-22 麒麟控股株式会社 抗过敏的组合物
EP1722804B1 (en) 2004-03-04 2015-01-21 E-L Management Corp. Skin treatment method with lactobacillus extract
MXPA06015184A (es) * 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
FR2872047B1 (fr) * 2004-06-23 2007-06-15 Oreal Composition pour peaux sensibles associant cation mineral et probiotique(s)
WO2006037922A1 (fr) * 2004-10-04 2006-04-13 L'oreal Composition cosmetique et/ou dermatologique pour peaux sensibles
FR2876029B1 (fr) * 2004-10-04 2008-11-14 Oreal Composition cosmetique et/ou dermatologique pour peaux sensibles.
US20060269508A1 (en) * 2005-03-29 2006-11-30 Trejo Amy V Means for regulating the cosmetic appearance and/or health of human keratinous tissue
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
JP2008061513A (ja) * 2006-09-04 2008-03-21 Himawari Nyugyo Kk 免疫バランスを正常化するラクトバチルス属乳酸菌及びそれを用いた飲食品
FR2908784B1 (fr) * 2006-11-17 2012-12-14 Oreal Utilisation cosmetique d'une proteine de la famille des ribonucleases
FR2912917B1 (fr) * 2007-02-26 2012-05-18 Oreal Milieu conditionne et ses utilisations
FR2920305B1 (fr) * 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
WO2010013182A1 (en) * 2008-07-29 2010-02-04 L'oreal Cosmetic use of microorganism(s) for the treatment of scalp disorders
FR2937547B1 (fr) * 2008-10-28 2012-11-09 Oreal Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses
FR2937536B1 (fr) * 2008-10-28 2016-07-01 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement du cuir chevelu gras

Also Published As

Publication number Publication date
JP2011529484A (ja) 2011-12-08
CN102105132B (zh) 2014-12-10
ES2524367T3 (es) 2014-12-05
WO2010013179A1 (en) 2010-02-04
US8951775B2 (en) 2015-02-10
US20110182861A1 (en) 2011-07-28
FR2938437A1 (fr) 2010-05-21
EP2306970A1 (en) 2011-04-13
CN102105132A (zh) 2011-06-22
EP2306970B1 (en) 2014-09-10
BRPI0916693A2 (pt) 2017-07-04
FR2938437B1 (fr) 2020-03-27
PT2306970E (pt) 2014-12-17

Similar Documents

Publication Publication Date Title
PL2306970T3 (pl) Zastosowanie kosmetyczne Lactobacillus paracasei w leczeniu skóry tłustej
PT2149368T (pt) Utilização cosmética e dermatológica de microrganismos probióticos lactobacillus paracasei para o tratamento de distúrbios do couro cabeludo oleoso
TWI348920B (en) Whitening agent and skin care agent
SG10201608068SA (en) Compositions And Methods For Skin Care
PL2278952T3 (pl) Środki do czyszczenia skóry i rąk
ZA201107917B (en) Applicator device for cosmetic and/or medical use
EP2392314A4 (en) OILY CAPILLARY COSMETICS
EP2382010A4 (en) METHOD AND SYSTEMS FOR FAT REDUCTION AND / OR TREATMENT OF CELLULITE
EP2168568A4 (en) SKIN COSMETICS
GB0810586D0 (en) Composition for the treatment of hair loss and baldness
GB2483419B (en) Formulations for the treatment of deep tissue pain
PT2407151T (pt) Composição para o tratamento de lesões da pele e/ou unhas
EP2174639A4 (en) COSMETICS FOR THE APPLICABLE BODY ON WET SKIN
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
ZA201008693B (en) Foam skin care cream
GB0800145D0 (en) Skincare treatment
IL215831A0 (en) Use of allopurinol for the treatment of hand foot skin reaction
GB0822486D0 (en) Compounds for use in the treatment of pain
ZA201101332B (en) The use of herbs in hair relaxation
GB0814043D0 (en) The treatment of skin disorders
IL189569A0 (en) Cosmetic and dermatological composition for psoriatic skin treatment
GB0901175D0 (en) The treatment of skin aging
GB0819037D0 (en) Skin treatment formulation
PH32007000160S1 (en) Skin massaging and cleansing implement
IL217880A0 (en) Cosmetic skin rejuvination